UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Safety of nintedanib plus docetaxel in advanced non-squamous NSCLC (nsNSCLC) patients: The preliminary results of the SENECA (second-line nintedanib in non-small cell lung cancer) trial

Annals of oncology, 2018-10, Vol.29, p.viii506-viii507

2018

Volltextzugriff (PDF)

Accumulation and tissue distribution of mercury and selenium in striped dolphins ( Stenella coeruleoalba) from the Mediterranean Sea (southern Italy)

Environmental pollution (1987), 2002, Vol.116 (2), p.265-271

2002

Volltextzugriff (PDF)

VEGF concentration from plasma‐activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model

Journal of cellular and molecular medicine, 2009-03, Vol.13 (3), p.555-561

2009

Volltextzugriff (PDF)

Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale)

Annals of oncology, 2006-06, Vol.17 (suppl-7), p.vii15-vii17

2006

Volltextzugriff (PDF)

31 HIGH ACTIVITY OF SEQUENTIAL COMBINATION OF LOW DOSE CHEMO-MODULATING TEMOZOLOMIDE (TMZ) + FOTEMUSTINE (FM) IN METASTATIC MELANOMA (MM). A FEASIBILITY STUDY

Cancer treatment reviews, 2010, Vol.36, p.S104-S104

2010

Volltextzugriff (PDF)

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

Journal of clinical oncology, 2005-08, Vol.23 (22), p.4866-4875

2005

Volltextzugriff (PDF)

28 BREAST CANCER TISSUE TRYPTASE EXPRESSION AS A NEW POSSIBLE ANTIANGIOGENETIC TARGET

Cancer treatment reviews, 2010, Vol.36, p.S103-S103

2010

Volltextzugriff (PDF)

64 WHAT ABOUT WORKING AFTER CANCER?

Cancer treatment reviews, 2010, Vol.36, p.S113-S114

2010

Volltextzugriff (PDF)

59 POST-TRAUMATIC GROWTH IN LONG TERM CANCER SURVIVORS

Cancer treatment reviews, 2010, Vol.36, p.S112-S112

2010

Volltextzugriff (PDF)

P106 Breast cancer tissue tryptase expression as a new possible antiangiogenic target

Breast (Edinburgh), 2011, Vol.20, p.S18-S18

2011

Volltextzugriff (PDF)

5 PANITUMUMAB PLUS CHEMOTHERAPY AS SALVAGE TREATMENT IN PRETREATED ADVANCED COLORECTAL CANCER PATIENTS: A SINGLE INSTITUTION'S EXPERIENCE

Cancer treatment reviews, 2010, Vol.36, p.S96-S96

2010

Volltextzugriff (PDF)

Mast cells positive to Tryptase correlates with protease-activated receptor-2 expression and microvascular density in breast cancer patients

BMC geriatrics, 2010-08, Vol.10 (S1), p.A114-A114, Article A114

2010

Volltextzugriff (PDF)

1815MO Two simplified dexamethasone (DEX)-sparing regimens with NEPA for the prevention of emesis caused by cisplatin (DDP): A phase III, controlled, non-inferiority trial

Annals of oncology, 2020-09, Vol.31, p.S1048-S1048

2020

Volltextzugriff (PDF)

Epithelial ovarian cancer: second and third line chemotherapy (review)

International journal of oncology, 2002-07, Vol.21 (1), p.179

2002

Volltextzugriff (PDF)

An interdisciplinary early simultaneous palliative approach in metastatic non-small cell lung cancer: preliminary data in outpatient setting

Annals of oncology, 2015-10, Vol.26, p.vi118

2015

Volltextzugriff (PDF)

Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study

Oncology, 2005-01, Vol.68 (4-6), p.438-445

2005

Volltextzugriff (PDF)

Real life experience with nivolumab in patients (pts) with advanced non-squamous NSCLC (nSq-NSCLC) exhibiting KRAS mutations: The Italian Expanded Access Program (EAP)

Annals of oncology, 2017-09, Vol.28, p.v471-v472

2017

Volltextzugriff (PDF)

P2.04-84 NSCLC Survival Expectancy for Patients Treated with Docetaxel/Nintedanib in the SENECA Trial and Previous Immunotherapy

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S742-S743

2019

Volltextzugriff (PDF)

P3.06-003 What Do the Children Think about Smoking and How Are They Helped in Prevention?

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2295-S2295

2017

Volltextzugriff (PDF)

MA 01.07 Lanreotide Maintenance in SCLC Expressing Somatostatine Receptors: Efficacy Results of Multicenter Randomized G04.2011 trial

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1801-S1801

2017

Volltextzugriff (PDF)

P1.01-73 Preliminary Results of the SENECA (SEcond Line NintEdanib in Non-Small Cell Lung CAncer) Trial: An Italian Experience

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S490-S491

2018

Volltextzugriff (PDF)

Efficacy and safety of nivolumab in elderly patients (pts) with advanced squamous non small cell lung cancer (Sq-NSCLC) participating in the expanded access programme (EAP) in Italy

Annals of oncology, 2016-10, Vol.27, p.vi369-vi369

2016

Volltextzugriff (PDF)

SIOG2021-0013 - Evaluation of dexamethasone (DEX)-sparing regimens, administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) in older patients receiving high-dose cisplatin

Journal of geriatric oncology, 2021-12, Vol.12 (8), p.S18-S19

2021

Volltextzugriff (PDF)

Evaluation of dexamethasone (DEX)-sparing regimens, administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) in older patients receiving high-dose cisplatin

Journal of geriatric oncology, 2021-12, Vol.12 (8), p.S18-S19

2021

Volltextzugriff (PDF)

Epirubicin, taxotere and fluorouracil modulated by folinic acid in the treatment of advanced gastric cancer: A phase II study of the Gruppo Oncologico dell’ Italia Meridionale (GOIM)

European journal of cancer supplements, 2008-10, Vol.6 (14), p.107-112

2008

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Humans
(19)
Oncology
(15)
Female
(10)
Hematology, Oncology And Palliative Medicine
(8)
Aged
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Middle Aged
(7)
Adult
(6)
Biological And Medical Sciences
(6)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(5)
Chemotherapy
(5)
Treatment Outcome
(5)
Male
(4)
Medical Sciences
(4)
Patients
(4)
Tumors
(4)
Animals
(3)
Breast Cancer
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety of nintedanib plus docetaxel in advanced non-squamous NSCLC (nsNSCLC) patients: The preliminary results of the SENECA (second-line nintedanib in non-small cell lung cancer) trial

Accumulation and tissue distribution of mercury and selenium in striped dolphins ( Stenella coeruleoalba) from the Mediterranean Sea (southern Italy)

VEGF concentration from plasma‐activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model

Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale)

31 HIGH ACTIVITY OF SEQUENTIAL COMBINATION OF LOW DOSE CHEMO-MODULATING TEMOZOLOMIDE (TMZ) + FOTEMUSTINE (FM) IN METASTATIC MELANOMA (MM). A FEASIBILITY STUDY

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

28 BREAST CANCER TISSUE TRYPTASE EXPRESSION AS A NEW POSSIBLE ANTIANGIOGENETIC TARGET

64 WHAT ABOUT WORKING AFTER CANCER?

59 POST-TRAUMATIC GROWTH IN LONG TERM CANCER SURVIVORS

P106 Breast cancer tissue tryptase expression as a new possible antiangiogenic target

5 PANITUMUMAB PLUS CHEMOTHERAPY AS SALVAGE TREATMENT IN PRETREATED ADVANCED COLORECTAL CANCER PATIENTS: A SINGLE INSTITUTION'S EXPERIENCE

Mast cells positive to Tryptase correlates with protease-activated receptor-2 expression and microvascular density in breast cancer patients

1815MO Two simplified dexamethasone (DEX)-sparing regimens with NEPA for the prevention of emesis caused by cisplatin (DDP): A phase III, controlled, non-inferiority trial

Epithelial ovarian cancer: second and third line chemotherapy (review)

An interdisciplinary early simultaneous palliative approach in metastatic non-small cell lung cancer: preliminary data in outpatient setting

Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study

Real life experience with nivolumab in patients (pts) with advanced non-squamous NSCLC (nSq-NSCLC) exhibiting KRAS mutations: The Italian Expanded Access Program (EAP)

P2.04-84 NSCLC Survival Expectancy for Patients Treated with Docetaxel/Nintedanib in the SENECA Trial and Previous Immunotherapy

P3.06-003 What Do the Children Think about Smoking and How Are They Helped in Prevention?

MA 01.07 Lanreotide Maintenance in SCLC Expressing Somatostatine Receptors: Efficacy Results of Multicenter Randomized G04.2011 trial

P1.01-73 Preliminary Results of the SENECA (SEcond Line NintEdanib in Non-Small Cell Lung CAncer) Trial: An Italian Experience

Efficacy and safety of nivolumab in elderly patients (pts) with advanced squamous non small cell lung cancer (Sq-NSCLC) participating in the expanded access programme (EAP) in Italy

SIOG2021-0013 - Evaluation of dexamethasone (DEX)-sparing regimens, administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) in older patients receiving high-dose cisplatin

Evaluation of dexamethasone (DEX)-sparing regimens, administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) in older patients receiving high-dose cisplatin

Epirubicin, taxotere and fluorouracil modulated by folinic acid in the treatment of advanced gastric cancer: A phase II study of the Gruppo Oncologico dell’ Italia Meridionale (GOIM)

Suchergebnisse filtern